Target intelligence / Profile preview

Sialic acid binding Ig-like lectin 27, pseudogene (SIGLEC27P)

Target
SIGLEC27P
Molecular classification
Other (Pseudogene), Immunoglobulin superfamily (by homology, not function)
01

Overview

SIGLEC27P is a human pseudogene that is annotated as "Sialic acid binding Ig-like lectin 27, pseudogene." It belongs to a family of sialic acid-recognizing immunoglobulin-like lectins (Siglecs), but does not produce a functional protein due to disruptive mutations in the gene sequence[3][1][7]. The "pseudogene" classification indicates it is evolutionarily related to gene-encoded receptors with potential immune regulatory functions but is not itself expressed as a protein or associated with known biological activities or disease mechanisms[4][5][6]. Synonyms include SIGLECP11[1][3][7]. There is no evidence of molecular function, therapeutic relevance, biomarker status, or drug interactors for SIGLEC27P. Summary: SIGLEC27P is a pseudogene and not a functional protein target; it is unsuitable for therapeutic targeting, disease association studies, or biomarker development[3][1][7].

Other names
SIGLECP11
02

Biological functions

Other (No known biological function; does not encode a functional protein in humans)
03

Disease associations

Other (No known disease involvement; pseudogenes generally do not play direct roles in disease)

Beyond the preview

Go deeper on Sialic acid binding Ig-like lectin 27, pseudogene (SIGLEC27P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid binding Ig-like lectin 27, pseudogene (SIGLEC27P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call